Literature DB >> 23905568

Rehabilitation for cirrhotic patients discharged after hepatic encephalopathy improves survival.

Michala Maj Andersen1, Søren Aunt, Nanna Martin Jensen, Christian Homann, Joan Manniche, Svend Svendsen, Erik Christensen, Astrid Reher-Langberg, Frank Vinholt Schiødt.   

Abstract

INTRODUCTION: The 1-year mortality of cirrhotic patients with hepatic encephalopathy (HE) is approximately 60-80% in recent studies. We aimed to establish a rehabilitation out-patient clinic (RC) for alcoholic cirrhotic patients sur-viving HE.
MATERIAL AND METHODS: Prospectively, patients surviving HE were offered participation in the RC and were seen by a nurse for a one-hour interview with 1-3 weeks' interval after discharge and by a physician, if needed. Clinical, psychological and social problems were identified and addressed. Alcohol consumption was recorded and alcohol cessation was encouraged at each visit. Minimal or overt HE prompted referral to the Liver Unit. The patients were compared with HE patients discharged in 2008 (the control group).
RESULTS: A total of 19 patients were included in the RC group and compared with the 14 patients of the control group. The Child-Pugh score was higher in the RC group (median 13; range 8-14) than in the control group (median 11; range 7-13) (p = 0.033), whereas other clinical, demographic and biochemical parameters did not differ between the two groups. One-year survival was higher in the RC group (16/19; 84%) than in the control group versus (5/14; 36%) (p = 0.012). The log-rank test confirmed an improved survival for the RC group (p = 0.008). The economic costs of subsequent hospital admissions did not differ between the two groups. In the RC group, alcohol consumption was reduced in all but two patients.
CONCLUSION: Survival was significantly improved for patients in the rehabilitation clinic. The improved survival did not subsequently cause higher hospital admission costs. FUNDING: not relevant. TRIAL REGISTRATION: not relevant.

Entities:  

Mesh:

Year:  2013        PMID: 23905568

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  6 in total

Review 1.  Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review.

Authors:  Anam Khan; Aylin Tansel; Donna L White; Waleed Tallat Kayani; Shah Bano; Jan Lindsay; Hashem B El-Serag; Fasiha Kanwal
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-06       Impact factor: 11.382

Review 2.  Covert Hepatic Encephalopathy: Can My Patient Drive?

Authors:  Jawaid Shaw; Jasmohan S Bajaj
Journal:  J Clin Gastroenterol       Date:  2017-02       Impact factor: 3.062

Review 3.  The Impact of Social Workers in Cirrhosis Care: a Systematic Review.

Authors:  Nneka N Ufere; Jan Hinson; Simon Finnigan; Elizabeth E Powell; John Donlan; Cathy Martin; Phil Clark; Patricia C Valery
Journal:  Curr Treat Options Gastroenterol       Date:  2022-04-19

4.  Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin.

Authors:  Guy Neff; Woodie Zachry
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

5.  Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy.

Authors:  Siamak M Seraj; Emily J Campbell; Sarah K Argyropoulos; Kara Wegermann; Raymond T Chung; James M Richter
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

Review 6.  Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows.

Authors:  Giovanni Addolorato; Gabriele A Vassallo; Antonio Mirijello; Antonio Gasbarrini
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.